| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/08/2023 | Satsuma Pharmaceuticals, Inc. | STSA | Disposition | Stock Option (right to buy) | 80k | $4.60 | $368k | | 06/06/2023 |
| 06/08/2023 | Satsuma Pharmaceuticals, Inc. | STSA | Disposition | Stock Option (right to buy) | 190k | $3.46 | $657.4k | | 06/06/2023 |
| 06/08/2023 | Satsuma Pharmaceuticals, Inc. | STSA | Disposition | Stock Option (right to buy) | 72.3k | $4.56 | $329.9k | | 06/06/2023 |
| 06/08/2023 | Satsuma Pharmaceuticals, Inc. | STSA | Disposition | Stock Option (right to buy) | 76.6k | $1.04 | $79.7k | | 06/06/2023 |
| 06/08/2023 | Satsuma Pharmaceuticals, Inc. | STSA | Disposition | Stock Option (right to buy) | 60k | $29.00 | $1.7M | | 06/06/2023 |
| 06/06/2023 | Satsuma Pharmaceuticals, Inc. | STSA | Other | Common Stock, $0.0001 par value | 13.9k | $0.91 | $12.6k | | 06/06/2023 |
| 06/03/2022 | Satsuma Pharmaceuticals, Inc. | STSA | Grant | Stock Option (Right to Buy) | 190k | $3.46 | $657.4k | | 06/03/2022 |
| 12/03/2020 | Satsuma Pharmaceuticals, Inc. | STSA | Grant | Stock Option (Right to Buy) | 80k | $4.60 | $368k | | 12/03/2020 |
| 09/01/2020 | Satsuma Pharmaceuticals, Inc. | STSA | Exercise | Stock Option (Right to Buy) | 750 | $4.56 | $3.4k | | 09/01/2020 |
| 09/01/2020 | Satsuma Pharmaceuticals, Inc. | STSA | Sale | Common Stock, $0.0001 par value | 750 | $22.19 | $16.6k | | 09/01/2020 |
| 08/05/2020 | Satsuma Pharmaceuticals, Inc. | STSA | Exercise | Stock Option (Right to Buy) | 1000 | $4.56 | $4.6k | | 08/05/2020 |
| 08/05/2020 | Satsuma Pharmaceuticals, Inc. | STSA | Sale | Common Stock, $0.0001 par value | 1000 | $25.00 | $25k | | 08/05/2020 |
| 07/01/2020 | Satsuma Pharmaceuticals, Inc. | STSA | Sale | Common Stock, $0.0001 par value | 300 | $25.63 | $7.7k | | 07/01/2020 |
| 07/01/2020 | Satsuma Pharmaceuticals, Inc. | STSA | Sale | Common Stock, $0.0001 par value | 394 | $26.70 | $10.5k | | 07/01/2020 |
| 07/01/2020 | Satsuma Pharmaceuticals, Inc. | STSA | Sale | Common Stock, $0.0001 par value | 306 | $27.59 | $8.4k | | 07/01/2020 |
| 07/01/2020 | Satsuma Pharmaceuticals, Inc. | STSA | Exercise | Stock Option (Right to Buy) | 1000 | $4.56 | $4.6k | | 07/01/2020 |
| 06/23/2020 | Satsuma Pharmaceuticals, Inc. | STSA | Exercise | Stock Option (Right to Buy) | 2.1k | $1.04 | $2.2k | | 06/23/2020 |
| 06/23/2020 | Satsuma Pharmaceuticals, Inc. | STSA | Sale | Common Stock, $0.0001 par value | 2.1k | $35.23 | $74.5k | | 06/23/2020 |
| 06/01/2020 | Satsuma Pharmaceuticals, Inc. | STSA | Sale | Common Stock, $0.0001 par value | 1000 | $25.32 | $25.3k | | 06/01/2020 |
| 06/01/2020 | Satsuma Pharmaceuticals, Inc. | STSA | Exercise | Stock Option (Right to Buy) | 1000 | $4.56 | $4.6k | | 06/01/2020 |
| 05/20/2020 | Satsuma Pharmaceuticals, Inc. | STSA | Sale | Common Stock, $0.0001 par value | 2k | $25.00 | $50k | | 05/20/2020 |
| 05/20/2020 | Satsuma Pharmaceuticals, Inc. | STSA | Exercise | Stock Option (Right to Buy) | 2k | $4.56 | $9.1k | | 05/20/2020 |
| 03/11/2020 | Satsuma Pharmaceuticals, Inc. | STSA | Sale | Common Stock, $0.0001 par value | 1000 | $27.68 | $27.7k | | 03/11/2020 |
| 03/11/2020 | Satsuma Pharmaceuticals, Inc. | STSA | Exercise | Stock Option (Right to Buy) | 1000 | $4.56 | $4.6k | | 03/11/2020 |
| 03/04/2020 | Satsuma Pharmaceuticals, Inc. | STSA | Grant | Stock Option (Right to Buy) | 60k | $29.00 | $1.7M | | 03/04/2020 |
| 08/15/2018 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 14k | $8.58 | $120.5k | | 08/15/2018 |
| 08/15/2018 | Protagonist Therapeutics, Inc | PTGX | Grant | Common Stock | 21.1k | $0.00 | $0 | | 08/15/2018 |
| 02/28/2018 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 34k | $16.95 | $576.3k | | 02/28/2018 |
| 02/28/2018 | Protagonist Therapeutics, Inc | PTGX | Grant | Common Stock | 6k | $0.00 | $0 | | 02/28/2018 |
| 12/18/2017 | Protagonist Therapeutics, Inc | PTGX | Sale | 12/18/2017 | 8k | $20.00 | $160k | | 12/18/2017 |
| 12/18/2017 | Protagonist Therapeutics, Inc | PTGX | Exercise | Employee Stock Option (right to buy) | 4k | $1.16 | $4.6k | | 12/18/2017 |
| 12/18/2017 | Protagonist Therapeutics, Inc | PTGX | Exercise | Employee Stock Option (right to buy) | 4k | $4.21 | $16.8k | | 12/18/2017 |